Characteristics of Patients
Patients . | Diagnosis . | Relapse . | BMT . | Relapse/ Post-BMT . | DLI/ post-BMT . | Evolution . | Jurkat Killing >15% . |
---|---|---|---|---|---|---|---|
P2 | CML | — | No | — | — | CP1 | + |
P3 | CML acc | — | Yes | 4 mo | 7 mo | CR | − |
P4 | CML | — | No | — | — | CP1 | − |
P5 | CML | — | Yes | No | — | CR1 | − |
P6 | CML | — | No | — | — | CP1 | − |
P7 | CML | — | No | — | — | CP1 | − |
P8 | CML | — | No | — | — | CP1 | − |
P9 | CML | — | Yes | No | No | Death in CR | − |
P10 | CML | — | No | — | — | CP1 | + |
P12 | CML | — | No | — | — | CP1 | + |
P13 | CML | — | No | — | — | CP1 | − |
P25 | AML0 | — | No | — | — | No remission | − |
P1 | AML1 | — | Yes | 5 mo | 6 mo | Death in relapse | + |
P16 | AML1 | — | No | — | — | Death induction | − |
P15 | AML4 | — | No | — | — | CR1 | − |
P17 | AML4 | — | No | — | — | CR1 24 mo | + |
P18 | AML4 | 9 mo | No | — | — | Death | − |
P19 | AML4 | — | No | — | — | Death induction | − |
P20 | AML4 | — | No | — | — | Death induction | + |
P11 | AML5 | 12 mo | No | — | — | Death in relapse | + |
P21 | AML5 | — | No | — | — | CR1 10 months | + |
P22 | AML5 | 12 mo | No | 6 mo | planned | In relapse | + |
P23 | AML5 | — | Yes | — | — | CR1 | − |
P24 | AML5 | — | No | — | — | No remission | + |
P14 | PM in acut. | — | No | — | — | CR1 | − |
P26 | PM in acut. | — | No | — | — | No remission | + |
P27 | ALL | — | No | — | — | CR1 | − |
Patients . | Diagnosis . | Relapse . | BMT . | Relapse/ Post-BMT . | DLI/ post-BMT . | Evolution . | Jurkat Killing >15% . |
---|---|---|---|---|---|---|---|
P2 | CML | — | No | — | — | CP1 | + |
P3 | CML acc | — | Yes | 4 mo | 7 mo | CR | − |
P4 | CML | — | No | — | — | CP1 | − |
P5 | CML | — | Yes | No | — | CR1 | − |
P6 | CML | — | No | — | — | CP1 | − |
P7 | CML | — | No | — | — | CP1 | − |
P8 | CML | — | No | — | — | CP1 | − |
P9 | CML | — | Yes | No | No | Death in CR | − |
P10 | CML | — | No | — | — | CP1 | + |
P12 | CML | — | No | — | — | CP1 | + |
P13 | CML | — | No | — | — | CP1 | − |
P25 | AML0 | — | No | — | — | No remission | − |
P1 | AML1 | — | Yes | 5 mo | 6 mo | Death in relapse | + |
P16 | AML1 | — | No | — | — | Death induction | − |
P15 | AML4 | — | No | — | — | CR1 | − |
P17 | AML4 | — | No | — | — | CR1 24 mo | + |
P18 | AML4 | 9 mo | No | — | — | Death | − |
P19 | AML4 | — | No | — | — | Death induction | − |
P20 | AML4 | — | No | — | — | Death induction | + |
P11 | AML5 | 12 mo | No | — | — | Death in relapse | + |
P21 | AML5 | — | No | — | — | CR1 10 months | + |
P22 | AML5 | 12 mo | No | 6 mo | planned | In relapse | + |
P23 | AML5 | — | Yes | — | — | CR1 | − |
P24 | AML5 | — | No | — | — | No remission | + |
P14 | PM in acut. | — | No | — | — | CR1 | − |
P26 | PM in acut. | — | No | — | — | No remission | + |
P27 | ALL | — | No | — | — | CR1 | − |
Abbreviations: CML, chronic myelogenous leukemia; CML acc, CML in acceleration; PM in ac, primary myelofibrosis in blastic phase; AML, acute myeloblastic leukemia; ALL, acute lymphoblastic leukemia; CR1, first complete remission; CP1, first chronic phase.